Skip to content
Home
About
Approach
Pipeline
News & Resources
Contact
Menu
Home
About
Approach
Pipeline
News & Resources
Contact
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit
Press Releases
Author:
Duet Therapeutics
Published:
March 22, 2022
Date of Publication:
March 22, 2022
Link to Publication
Abstract:
Scopus BioPharma's Subsidiary - Duet Therapeutics - to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit (03.22.22) FINAL
×
